Press Releases – Perseus SENOLYTIX

Press Releases

Eos SENOLYTIX Presents Best-in-Class Preclinical Body Composition Data Highlighting Unique Muscle Mass Gains with MitoXcel™ Geropeptide PTC-2105 at the Sachs 2nd Annual Obesity & Cardiometabolic Innovation Forum

June 5, 2026

Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger

April 21, 2026

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

March 26, 2026

MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies

September 5, 2025

Brent Saunders Appointed as Advisory Board Chairman

February 21, 2025

Categories

Archives

© 2026 Perseus SENOLYTIX.